Two of Baupost Group’s recent biotech investments enjoyed big bounces Wednesday. Shares of Paratek surged 17.4 percent, to $34, on more than quadruple the stock’s average daily volume. The stock has now virtually doubled in just the past eight trading days. We recently reported that Boston-based Baupost disclosed that it owns 12 percent of the Boston-based drug company.
